Vir Biotechnology Inc (NASDAQ: VIR) is -38.99% lower on its value in year-to-date trading and has touched a low of $4.32 and a high of $14.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VIR stock was last observed hovering at around $5.11 in the last trading session, with the day’s gains setting it 1309994.89%.
Currently trading at $1310000.0, the stock is 3.66% and 2.93% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.39 million and changing 6.26% at the moment leaves the stock -26.29% off its SMA200. VIR registered -26.02% loss for a year compared to 6-month loss of -27.26%. The firm has a 50-day simple moving average (SMA 50) of $5.2753 and a 200-day simple moving average (SMA200) of $7.3665.
The stock witnessed a 7.10% gain in the last 1 month and extending the period to 3 months gives it a -12.14%, and is 4.62% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.90% over the week and 5.04% over the month.
Vir Biotechnology Inc (VIR) has around 408 employees, a market worth around $750.64M and $20.86M in sales. Profit margin for the company is -2769.04%. Distance from 52-week low is 25.69% and -62.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-51.03%).
The EPS is expected to grow by 16.37% this year
329.0 institutions hold shares in Vir Biotechnology Inc (VIR), with institutional investors hold 88.41% of the company’s shares. The shares outstanding are 138.06M, and float is at 89.08M with Short Float at 12.76%. Institutions hold 79.05% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 16.68 million shares valued at $148.49 million. The investor’s holdings represent 12.2466 of the VIR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 16.43 million shares valued at $146.26 million to account for 12.0632 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 12.85 million shares representing 9.4317 and valued at over $114.36 million, while STATE STREET CORP holds 3.7398 of the shares totaling 5.09 million with a market value of $45.34 million.
Vir Biotechnology Inc (VIR) Insider Activity
The most recent transaction is an insider sale by SATO VICKI L, the company’s Director. SEC filings show that SATO VICKI L sold 22,000 shares of the company’s common stock on Jul 01 ’25 at a price of $5.10 per share for a total of $0.11 million. Following the sale, the insider now owns 1.3 million shares.
